Evidence map›Paper›PMID 22509276›Full record

ArticlePloS one2012

A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity.

David H Lovett, Rajeev Mahimkar, Robert L Raffai, Leslie Cape, Elena Maklashina, Gary Cecchini, Joel S Karliner

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Framing Heartaches: The Cardiac ECM and the Effects of Age.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Novel Roles of MT1-MMP and MMP-2: Beyond the Extracellular Milieu.International journal of molecular sciences · 2022
    Review
  14. Review
  15. Review
  16. Doxycycline Decreases Atherosclerotic Lesions in the Aorta ofInternational journal of molecular sciences · 2022
    Article
  17. Article
  18. Understanding the genetics of intracranial aneurysms: A primer.Clinical neurology and neurosurgery · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

David H LovettDepartment of Medicine, San Francisco Department of Veterans Affairs Medical Center, University of California San Francisco, San Francisco, California, United States of America. david.lovett@va.gov
Rajeev Mahimkar
Robert L Raffai
Leslie Cape
Elena Maklashina
Gary Cecchini
Joel S Karliner
University of California, San Francisco · USSan Francisco VA Medical Center · US

Funding

Structure/Function of Complex ll OxidoreductasesR01GM061606 · NIGMS · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI CECCHINI, GARY, IVERSON, T M · 2001 to 2022
$9.1M
Mechanisms of Cardioprotection in Ischemia and FailureP01HL068738 · NHLBI · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI KARLINER, JOEL SAMUEL · 2002 to 2006
$8.6M
Role of apolipoprotein E4 in the progression and regression of atherosclerosisR01HL089871 · NHLBI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI RAFFAI, ROBERT · 2007 to 2011
$2.2M
Mitochondrial Matrix Metalloproteinase-2 and Cardiac InjuryI01BX000593 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI LOVETT, DAVID H · 2009 to 2014
–
THE ROLE OF ACETYLATION IN MITOCHONDRIAL FUNCTIONI01BX001077 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI CECCHINI, GARY · 2011 to 2014
–
BLRD VA I01 BX000593BLRD VA I01 BX001077NHLBI NIH HHS P01 HL068738NHLBI NIH HHS P01-HL-68738NHLBI NIH HHS R01 HL089871NHLBI NIH HHS R01-HL089871NIGMS NIH HHS R01 GM061606
6 · The paper itself

Abstract

backgroundExperimental and clinical evidence has pinpointed a critical role for matrix metalloproteinase-2 (MMP-2) in ischemic ventricular remodeling and systolic heart failure. Prior studies have demonstrated that transgenic expression of the full-length, 68 kDa, secreted form of MMP-2 induces severe systolic failure. These mice also had unexpected and severe mitochondrial structural abnormalities and dysfunction. We hypothesized that an additional intracellular isoform of MMP-2, which affects mitochondrial function is induced under conditions of systolic failure-associated oxidative stress. METHODOLOGY AND PRINCIPAL

findingsWestern blots of cardiac mitochondria from the full length MMP-2 transgenics, ageing mice and a model of accelerated atherogenesis revealed a smaller 65 kDa MMP-2 isoform. Cultured cardiomyoblasts subjected to transient oxidative stress generated the 65 kDa MMP-2 isoform. The 65 kDa MMP-2 isoform was also induced by hypoxic culture of cardiomyoblasts. Genomic database analysis of the MMP-2 gene mapped transcriptional start sites and RNA transcripts induced by hypoxia or epigenetic modifiers within the first intron of the MMP-2 gene. Translation of these transcripts yields a 65 kDa N-terminal truncated isoform beginning at M(77), thereby deleting the signal sequence and inhibitory prodomain. Cellular trafficking studies demonstrated that the 65 kDa MMP-2 isoform is not secreted and is present in cytosolic and mitochondrial fractions, while the full length 68 kDa isoform was found only in the extracellular space. Expression of the 65 kDa MMP-2 isoform induced mitochondrial-nuclear stress signaling with activation of the pro-inflammatory NF-κB, NFAT and IRF transcriptional pathways. By microarray, the 65 kDa MMP-2 induces an innate immunity transcriptome, including viral stress response genes, innate immunity transcription factor IRF7, chemokines and pro-apoptosis genes.

conclusionA novel N-terminal truncated intracellular isoform of MMP-2 is induced by oxidative stress. This isoform initiates a primary innate immune response that may contribute to progressive cardiac dysfunction in the setting of ischemia and systolic failure.

Indexed as

Immunity, InnateActive Transport, Cell NucleusAmino Acid SequenceAnimalsCell HypoxiaCell LineCell NucleusEnzyme ActivationHeart InjuriesHumansI-kappa B KinaseInterferon Regulatory Factor-7Intracellular SpaceIsoenzymesMatrix Metalloproteinase 2MiceI-kappa B KinaseInterferon Regulatory Factor-7Irf7 protein, mouseIsoenzymesMatrix Metalloproteinase 2Protein Kinase InhibitorsRNA, Messenger

Identifiers

PMID22509276
PMCPMC3317925
OpenAlexW2064413798

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.